Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray Combined With Esketamine in Suspension Laryngoscopy Surgery
NCT07880938Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of esketamine in Emergence agitation (EA) (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Incidence of emergence agitation within 60 minutes after surgery. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07880938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880938.